- Raised $55M funding round led by 83North, Sep 2023
- Raised $38M funding round led by Octopus Ventures, Mar 2021
- Raised $10M funding round led by Kreos Capital, Nov 2022
About
Ibex Medical Analytics uses artificial intelligence technology to develop clinical-grade solutions designed to detect cancer as accurately as a human pathologist. The companys Galen platform uses algorithms to analyze images, detect and grade cancer in biopsies, and point to other findings with high clinical importance, helping pathologists to reduce diagnostic error rates and enable a more efficient workflow. Deployed worldwide, Ibexs Galen Prostate and Galen Breast are AI-based cancer detection solutions used in routine clinical practice in pathology labs, with demonstrated success in detecting missed cancer cases. In addition, the company is developing computational prognostic and predictive tests that will enable enhanced patient population stratification and quicker personalized treatment selection.
Funding history · 5 rounds · $116.6M total
Q&A
- What is Ibex Medical Analytics' primary focus?
- Ibex Medical Analytics specializes in AI-powered cancer diagnostics for pathologists, developing clinical-grade solutions to detect cancer accurately using artificial intelligence.
- When was Ibex Medical Analytics founded?
- Ibex Medical Analytics was founded in January 2016.
- What is the total amount of funding raised by Ibex Medical Analytics?
- Ibex Medical Analytics has raised a total of $116.6 million USD.
- Who were the lead investors in Ibex Medical Analytics' September 2023 funding round?
- In September 2023, Ibex Medical Analytics raised $55 million with 83North as the lead investor.
- How many employees does Ibex Medical Analytics currently have?
- Ibex Medical Analytics has 51–200 employees.
- What is the name of Ibex Medical Analytics' core AI platform?
- Ibex Medical Analytics' core AI platform is called Galen, which uses algorithms to analyze images, detect and grade cancer in biopsies.
- Which AI-based cancer detection solutions are currently deployed by Ibex Medical Analytics?
- Ibex Medical Analytics has deployed Galen Prostate and Galen Breast, which are AI-based cancer detection solutions used in routine clinical practice in pathology labs.
- Who are the co-founders of Ibex Medical Analytics?
- The co-founders of Ibex Medical Analytics are Joseph (Yossi) Mossel, who serves as CEO, and Chaim Linhart, who is the CTO.
Team · 2
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | ibex-ai.com/ |
|---|---|
| linkedin.com/company/18096753 | |
| facebook.com/IbexMedAx | |
| YouTube | youtube.com/channel/UCxZlV1rPO2pHsuSJ-AubIxw |
Identifiers & details
| Founded | 2016-1 |
|---|---|
| Employees (exact) | 104 |
Radar intelligence
Open jobs — recruitee
| Total open | 4 |
|---|---|
| Remote | 0 |
| By department | R&D (1), BioPharma (1), COps (2) |
| By location | Tel Aviv, Tel Aviv, Israel (3), Remote job (1) |
| Title | Location | Department |
|---|---|---|
| Senior Algorithm Engineer - IL | Tel Aviv, Tel Aviv, Israel | R&D |
| Head of Precision Diagnostics - US | Remote job | BioPharma |
| Director of Customer Success - UK / IL | Tel Aviv, Tel Aviv, Israel | COps |
| Support Engineer - IL | Tel Aviv, Tel Aviv, Israel | COps |
Patents
| EPO | 2 |
|---|
Web history (Wayback)
| Domain | ibex-ai.com |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|